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Interestingly, locoregional recurrence was observed only in 
rectal cancer. The anastomosis site, the presacral area, and the 
pelvic wall were the places of locoregional recurrence. This 
result might reflect the importance of complete total mesorec-
tal excision in the management of rectal cancer, even in cases 
of early cancer. 
Even in early colorectal cancer, patients with adverse clinico-
pathologic characteristics have a risk of treatment failure, so 
close follow-up is mandatory for these patients. In another as-
pect, the validation of molecular biological markers as prog-
nostic factors should be mentioned. Since the clinicopathologic 
characteristics of the primary tunor are phenotypes of its bio-
logical characteristics, precise evaluation of molecular biolog-
ical characteristics could be the next era of research on risk 
assessment for early colorectal cancer. 
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For the last several decades, the prognosis for colorectal can-
cer has improved. All aspects of colorectal cancer treatments, 
including new chemotherapeutic drugs and standardization 
of surgical treatment, have contributed to this improvement 
in survival. Among them, the most important contribution is 
early detection of cancer through screening programs, followed 
by a curative resection of the tumor. Even though early detec-
tion of the cancer and a curative resection offer the best chance 
for a cure, still 10% of the tumors will recur after treatment for 
early colorectal cancer [1, 2]. 
Some clinicopathologic parameters, such as an infiltrative 
growth pattern of the tumor, lymphovascular invasion, and 
tumor budding, have been suggested as risk factors for treat-
ment failure in early colorectal cancer. Pathologically, tumor 
budding is defined as a single cell or a small cluster of cells away 
from the tumor mass. Tumor budding is regarded as not only 
a prognostic factor in early and advanced colorectal cancer, but 
also a risk factor of regional lymph nodes metastasis [3], and 
Keum et al. [4] found tumor budding in a primary tumor, for 
which recurrence was diagnosed during follow-up. Lympho-
vascular invasion has also been reported as an independent 
risk factor for regional lymph nodes metastasis and as an inde-
pendent prognostic factor in the management of early colorec-
tal cancer [5]. There is no doubt that patients with these risk 
factors should be followed with careful attention. 
In a study by Keum et al. [4], the recurrence pattern after a 
curative resection for early colorectal cancer was described. 
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